File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Treat to target for rheumatoid arthritis in 2014 – time tested triple therapy or logical biologics?

TitleTreat to target for rheumatoid arthritis in 2014 – time tested triple therapy or logical biologics?
Authors
Issue Date2014
PublisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwell-synergy.com/loi/ijrd
Citation
International Journal of Rheumatic Diseases , 2014, v. 17 n. 1, p. 1-3 How to Cite?
DescriptionOpen Access Journal
Persistent Identifierhttp://hdl.handle.net/10722/203067
ISSN
2021 Impact Factor: 2.558
2020 SCImago Journal Rankings: 0.795
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorMok, TMY-
dc.contributor.authorDanda, D-
dc.date.accessioned2014-09-19T11:29:25Z-
dc.date.available2014-09-19T11:29:25Z-
dc.date.issued2014-
dc.identifier.citationInternational Journal of Rheumatic Diseases , 2014, v. 17 n. 1, p. 1-3-
dc.identifier.issn1756-1841-
dc.identifier.urihttp://hdl.handle.net/10722/203067-
dc.descriptionOpen Access Journal-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwell-synergy.com/loi/ijrd-
dc.relation.ispartofInternational Journal of Rheumatic Diseases-
dc.rightsPreprint This is the pre-peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article]. Authors are not required to remove preprints posted prior to acceptance of the submitted version. Postprint This is the accepted version of the following article: [full citation], which has been published in final form at [Link to final article].-
dc.subject.meshAntirheumatic Agents - therapeutic use-
dc.subject.meshArthritis, Rheumatoid - diagnosis - drug therapy - immunology-
dc.subject.meshBiological Products - therapeutic use-
dc.subject.meshTumor Necrosis Factor-alpha - antagonists and inhibitors-
dc.titleTreat to target for rheumatoid arthritis in 2014 – time tested triple therapy or logical biologics?-
dc.typeArticle-
dc.identifier.emailMok, TMY: temy@hkucc.hku.hk-
dc.identifier.authorityMok, TMY=rp00490-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1111/1756-185X.12313-
dc.identifier.pmid24472259-
dc.identifier.scopuseid_2-s2.0-84893089050-
dc.identifier.hkuros235685-
dc.identifier.volume17-
dc.identifier.issue1-
dc.identifier.spage1-
dc.identifier.epage3-
dc.identifier.isiWOS:000330315200001-
dc.publisher.placeAustralia-
dc.identifier.issnl1756-1841-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats